Damien McDonald Biography and Net Worth

Damien McDonald is the Chief Executive Officer of LivaNova.

Previously, Mr. McDonald served as Chief Operating Officer of LivaNova. Prior to that, he was Group Executive and Corporate Vice President at Danaher Corporation where he led a $1.5-billion group of dental consumables companies. Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Additionally, Mr. McDonald previously led Zimmer’s spine division where he demonstrated his leadership skills, attracting a strong executive team that created a growth trajectory for the business unit. Earlier in his career, he worked with J&J’s Medical Device Franchises, including Ethicon, where he led marketing of the $2.5-billion medical device unit.

Mr. McDonald earned an MBA at the Institute for Management Development (IMD) in Lausanne, Switzerland, along with a Master of Science in International Economics from the University of Wales, U.K. He also holds a Bachelor of Economics degree and Bachelor of Pharmacy degree, both from the University of Queensland, Australia.

What is Damien McDonald's net worth?: The estimated net worth of Damien McDonald is at least $5.80 million as of March 30th, 2023. Mr. McDonald owns 111,847 shares of LivaNova stock worth more than $5,801,504 as of April 17th. This net worth evaluation does not reflect any other investments that Mr. McDonald may own. Learn More about Damien McDonald's net worth.
How do I contact Damien McDonald?: The corporate mailing address for Mr. McDonald and other LivaNova executives is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. LivaNova can also be reached via phone at 442033250660 and via email at [email protected]. Learn More on Damien McDonald's contact information.
Has Damien McDonald been buying or selling shares of LivaNova?: Damien McDonald has not been actively trading shares of LivaNova during the last ninety days. Most recently, Damien Mcdonald sold 2,220 shares of the business's stock in a transaction on Thursday, March 30th. The shares were sold at an average price of $42.55, for a transaction totalling $94,461.00. Following the completion of the sale, the chief executive officer now directly owns 111,847 shares of the company's stock, valued at $4,759,089.85. Learn More on Damien McDonald's trading history.
Who are LivaNova's active insiders?: LivaNova's insider roster includes Marco Dolci (SVP), Damien McDonald (CEO), Daniel Moore (Director), and Alfred Novak (Director). Learn More on LivaNova's active insiders.

Damien McDonald Insider Trading History at LivaNova

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/30/2023	Sell	2,220	$42.55	$94,461.00	111,847
12/15/2022	Sell	2,220	$54.56	$121,123.20	83,749
3/29/2022	Sell	2,784	$81.50	$226,896.00
12/13/2021	Sell	2,784	$81.50	$226,896.00
2/3/2020	Sell	1,000	$68.00	$68,000.00	64,016
1/2/2020	Sell	1,000	$75.68	$75,680.00	65,016
12/2/2019	Sell	1,000	$83.71	$83,710.00	66,016
11/1/2019	Sell	1,000	$73.70	$73,700.00
10/1/2019	Sell	1,000	$73.82	$73,820.00
9/3/2019	Sell	1,000	$77.00	$77,000.00	60,774
8/1/2019	Sell	1,000	$77.53	$77,530.00	61,774
7/1/2019	Sell	1,000	$72.60	$72,600.00
6/5/2019	Sell	1,000	$73.58	$73,580.00
6/8/2018	Sell	15,742	$96.51	$1,519,260.42

Damien McDonald Buying and Selling Activity at LivaNova

LivaNova Company Overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Today's Range

Now: $51.87

$51.87

$53.46

50 Day Range

MA: $53.51

$48.75

$57.12

2 Week Range

Now: $51.87

$42.75

$59.86

Volume

484,959 shs

Average Volume

610,994 shs

Market Capitalization

$2.80 billion

P/E Ratio

162.10

Dividend Yield

N/A

Beta

0.89

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…